AVEO Pharmaceuticals Inc. Sets New 1-Year Low at $2.01 (AVEO)
AVEO Pharmaceuticals (NASDAQ:AVEO) set a new 52-week low during mid-day trading on Wednesday, AmericanBankingNews.com reports. The stock traded as low as $2.01 and last traded at $2.07, with a volume of 323,861 shares. The stock had previously closed at $2.08.
AVEO Pharmaceuticals has a 52-week low of $2.03 and a 52-week high of $8.98. The stock has a 50-day moving average of $2.12 and a 200-day moving average of $3.35. The company’s market cap is $105.9 million.
AVEO Pharmaceuticals (NASDAQ:AVEO) last posted its quarterly earnings results on Thursday, August 1st. The company reported ($0.62) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.56) by $0.06. The company had revenue of $0.32 million for the quarter, compared to the consensus estimate of $4.30 million. During the same quarter last year, the company posted ($0.68) earnings per share. AVEO Pharmaceuticals’s revenue was down 83.2% compared to the same quarter last year. On average, analysts predict that AVEO Pharmaceuticals will post $-1.92 earnings per share for the current fiscal year.
AVEO Pharmaceuticals, Inc is a cancer therapeutics company discovering, developing and commercializing targeted cancer therapies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.